CooperVision to Spotlight Myopia Control and Management Advocacy at ESCRS

CooperVision will spotlight advancing myopia control and management as standard of care across all ocular health sectors at the 2023 European Society of Cataract and Refractive Surgeons (ESCRS) conference in Vienna.

On September 7, a thought leadership panel will be held at the Ophthalmology Futures Forum, moderated by Marcus Ang, MBBS, PhD, and Ian Flitcroft, DPhil, FRCOphth. Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision, will join several industry and clinical colleagues to debate 'Myopia in the Digital Age, Is Technology the Answer?' The discussion is scheduled to begin at 1400 CET at the Hilton Danube Waterfront.

The World Society of Paediatric Ophthalmology and Strabismus’ (WSPOS) Subspecialty Day, sponsored in part by CooperVision, will take place September 8. 'Correction and Control; The Value of Optical Interventions in Myopia Control,' will also be led by Dr. Lumb. She will engage Ian Flitcroft on his latest explorations regarding evidence-base in respect of low dose atropine and the broader consideration of a clinical management plan in addressing myopia in Western verses Asian populations.  

“The global scale of the myopia challenge and the availability of both optical and pharmacological treatments means that this isn’t a question of ophthalmology or optometry, but of cooperation and partnership,” Mr. Flitcroft said in a company news release.

Now prescribed in more than 30 countries, CooperVision’s MiSight 1 day is designed to slow the progression of myopia in children. The company also offers a range of orthokeratology contact lens designs and a spectacle lens with with Diffusion Optics Technology for myopia management. For more information on the Opthalmology Futures Forum, including free registration to view the panels online, visit www.ophthalmology-futures.com.